Below are the financial statements of IDEXX Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 288.27a | 453.93a |
| Accounts receivable, net | 473.58a | 457.45a |
| Inventories | 381.88a | 380.28a |
| Other current assets | 256.18a | 203.6a |
| Total current assets | 1,399.9a | 1,495.25a |
| Long-term assets | — | — |
| Property and equipment, net | 713.12a | 702.18a |
| Operating lease right-of-use assets | 116.13a | 115.5a |
| Goodwill | 405.1a | 365.96a |
| Intangible assets, net | 111.68a | 84.5a |
| Other long-term assets | 547.52a | 496.53a |
| Total long-term assets | 1,893.55a | 1,764.67a |
| Total assets | 3,293.44a | 3,259.93a |
| Liabilities and stockholders’ equity | — | — |
| Current liabilities | — | — |
| Accounts payable | 114.21a | 110.64a |
| Accrued liabilities | 502.12a | 478.71a |
| Credit facility | 250a | 250a |
| Current portion of long-term debt | 167.79a | 75a |
| Current portion of deferred revenue | 33.8a | 37.2a |
| Total current liabilities | 1,067.92a | 951.55a |
| Long-term liabilities | — | — |
| Deferred income tax liabilities | 11.31a | 7.24a |
| Long-term debt, net of current portion | 449.79a | 622.88a |
| Long-term deferred revenue, net of current portion | 26.94a | 28.53a |
| Long-term operating lease liabilities, net of current portion | 97.84a | 99.67a |
| Other long-term liabilities | 44.34a | 65.53a |
| Total long-term liabilities | 630.21a | 823.85a |
| Total liabilities | 1,698.13a | 1,775.4a |
| Stockholders’ equity | — | — |
| Common stock | 10.78a | 10.75a |
| Additional paid-in capital | 1,673.86a | 1,569.57a |
| Deferred stock units | 5.89a | 5.53a |
| Retained earnings | 5,332.44a | 4,444.57a |
| Accumulated other comprehensive loss | -93.65a | -71.21a |
| Treasury stock, at cost | -5,334.01a | -4,474.68a |
| Total IDEXX Laboratories, Inc. stockholders’ equity | 1,595.31a | 1,484.53a |
| Total liabilities and stockholders’ equity | 3,293.44a | 3,259.93a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.